A detailed history of Callan Family Office, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Callan Family Office, LLC holds 3,723 shares of MDT stock, worth $300,595. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,723
Previous 2,915 27.72%
Holding current value
$300,595
Previous $229 Million 46.09%
% of portfolio
0.06%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$76.84 - $91.03 $62,086 - $73,552
808 Added 27.72%
3,723 $335 Million
Q2 2024

Jul 25, 2024

BUY
$78.71 - $87.02 $229,439 - $253,663
2,915 New
2,915 $229 Million
Q1 2023

May 12, 2023

BUY
$76.72 - $87.58 $445,819 - $508,927
5,811 New
5,811 $468 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $107B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.